Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted Therapy

Overview of attention for article published in Diagnostics, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,495 followers.

RT @DerekBAllisonMD: Nice review of precision medicine in ovarian cancer! Glad to be part of the team! @UKMarkey https://t.co/bhYIB8P0rN

Nice review of precision medicine in ovarian cancer! Glad to be part of the team! @UKMarkey https://t.co/bhYIB8P0rN

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.